ET
GILD icon

Equitable Trust’s Gilead Sciences GILD Stock Holding History

Equitable Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.47M Buy
50,119
+495
+1% +$69.5K 0.31% 71
2026
Q2 		$6.27M Sell
49,624
-553
-1% -$72.9K 0.26% 82
2026
Q1 		$6.99M Buy
50,177
+714
+1% +$100K 0.32% 63
2025
Q4 		$6.07M Buy
49,463
+32,310
+188% +$3.93M 0.27% 70
2025
Q3 		$1.9M Hold
17,153
– – 0.09% 157
2025
Q2 		$1.9M Sell
17,153
-292
-2% -$31.1K 0.09% 157
2025
Q1 		$1.95M Buy
17,445
+265
+2% +$27.3K 0.11% 155
2024
Q4 		$1.59M Sell
17,180
-424
-2% -$38.2K 0.09% 164
2024
Q3 		$1.48M Hold
17,604
– – 0.09% 161
2024
Q2 		$1.21M Buy
17,604
+1,029
+6% +$68.7K 0.08% 169
2024
Q1 		$1.21M Sell
16,575
-2,494
-13% -$192K 0.08% 173
2023
Q4 		$1.54M Sell
19,069
-483
-2% -$37.6K 0.12% 140
2023
Q3 		$1.47M Buy
19,552
+1,255
+7% +$96.5K 0.12% 138
2023
Q2 		$1.41M Buy
18,297
+484
+3% +$38.6K 0.11% 144
2023
Q1 		$1.48M Sell
17,813
-771
-4% -$63.9K 0.12% 142
2022
Q4 		$1.6M Buy
+18,584
New +$1.47M 0.13% 144
2021
Q3 		– Sell
-3,446
Closed -$237K – 367
2021
Q2 		$237K Buy
+3,446
New +$230K 0.02% 333

Other funds holding GILD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Equitable Trust's GILD Position: Q3 2026 in Review

Equitable Trust increased its Gilead Sciences (GILD) stake by 1% in Q3 2026, buying an estimated $69.5K and bringing the position to 50,119 shares worth $7.47M. The position accounts for 0.31% of the portfolio, ranked #71.

Equitable Trust first reported a position in GILD in Q2 2021 and has held it in 17 quarters since. 416 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Equitable Trust held 50,119 shares of Gilead Sciences worth $7.47M as of Q3 2026.
  • Equitable Trust bought 495 Gilead Sciences shares in Q3 2026, an estimated $69.5K.
  • Gilead Sciences made up 0.31% of Equitable Trust's portfolio in Q3 2026, its #71 holding.
  • Equitable Trust first reported a position in Gilead Sciences in Q2 2021 and has held it in 17 quarters since.
  • 416 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Equitable Trust's 13F filing for Q3 2026, filed 13 Oct 2026.